arrow
N

Neil C. Dalvie

Harvard Medical School
H指数:17
被引数:969

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
MSPHERE
IF3.1
2022-08-3110
OAAI
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity
2022-07-2053
OAAI
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
2022-06-0616
OAAI
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques

HBsAg病毒样颗粒上显示的SARS-CoV-2受体结合域在猕猴中引起保护性免疫

2022-03-1822
OAAI
Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2

磷酸盐介导的RBD免疫原和分子佐剂与明矾的共锚定可增强针对SARS-CoV-2的体液免疫

2021-12-1026
OAAI
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
2021-09-0764
OAAI
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus
2021-05-0110
OAAI
Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
2021-03-0118
OAAI